Literature DB >> 17641210

Influence of adenosine A(1)-receptor blockade and vagotomy on the gasping and heart rate response to hypoxia in rats during early postnatal maturation.

James E Fewell1, Chunfen Zhang, Anne M Gillis.   

Abstract

Failure to autoresuscitate from apnea has been suggested to play a role in sudden infant death. Little is known, however, about factors that influence the gasping and heart rate response to severe hypoxia that are fundamental to successful autoresuscitation in the newborn. The present experiments were carried out on 184 rat pups to investigate the influence of the parasympathetic nervous system, as well as adenosine, in mediating the profound bradycardia that occurs with the onset of hypoxic-induced primary apnea and in modulating hypoxic gasping. On days 1 to 2, days 5 to 6, and days 10 to 11 postpartum and following bilateral cervical vagotomy (VAG) or administration of a selective adenosine A(1) receptor antagonist (8-cyclopentyl-1,3-dipropylxanthine; DPCPX), each pup was exposed to a single period of severe hypoxia produced by breathing an anoxic gas mixture (97% N(2)-3% CO(2)). Exposure to severe hypoxia resulted in an age-dependent decrease in heart rate (P < 0.001), accentuated with increasing postnatal age, that was attenuated in all age groups by DPCPX but not by VAG. Furthermore, DPCPX but not VAG decreased the time to last gasp but increased the total number of gasps in the 1- to 2-day-old and 5- to 6-day-old pups but not in the 10- to 11-day-old pups during exposure to severe hypoxia. Thus our data provide evidence that adenosine acting via adenosine A(1) receptors plays a role in modulating hypoxic gasping and in mediating the profound bradycardia that occurs coincident with hypoxic-induced primary apnea in rats during early postnatal life.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17641210     DOI: 10.1152/japplphysiol.01421.2006

Source DB:  PubMed          Journal:  J Appl Physiol (1985)        ISSN: 0161-7567


  8 in total

1.  Prenatal nicotine exposure alters postnatal cardiorespiratory integration in young male but not female rats.

Authors:  Carie R Boychuk; Linda F Hayward
Journal:  Exp Neurol       Date:  2011-09-16       Impact factor: 5.330

2.  Postnatal loss of brainstem serotonin neurones compromises the ability of neonatal rats to survive episodic severe hypoxia.

Authors:  Kevin J Cummings; Julie C Hewitt; Aihua Li; John A Daubenspeck; Eugene E Nattie
Journal:  J Physiol       Date:  2011-09-12       Impact factor: 5.182

3.  Failed heart rate recovery at a critical age in 5-HT-deficient mice exposed to episodic anoxia: implications for SIDS.

Authors:  Kevin J Cummings; Kathryn G Commons; Julie C Hewitt; John A Daubenspeck; Aihua Li; Hannah C Kinney; Eugene E Nattie
Journal:  J Appl Physiol (1985)       Date:  2011-06-16

4.  Caffeine improves the ability of serotonin-deficient (Pet-1-/-) mice to survive episodic asphyxia.

Authors:  Kevin J Cummings; Kathryn G Commons; Felicia L Trachtenberg; Aihua Li; Hannah C Kinney; Eugene E Nattie
Journal:  Pediatr Res       Date:  2012-10-24       Impact factor: 3.756

5.  5-HT2 receptors modulate excitatory neurotransmission to cardiac vagal neurons within the nucleus ambiguus evoked during and after hypoxia.

Authors:  O Dergacheva; H Kamendi; X Wang; R A Pinol; J Frank; C Gorini; H Jameson; M R Lovett-Barr; D Mendelowitz
Journal:  Neuroscience       Date:  2009-09-20       Impact factor: 3.590

6.  Tonic neuromodulation of the inspiratory rhythm generator.

Authors:  Fernando Peña-Ortega
Journal:  Front Physiol       Date:  2012-07-20       Impact factor: 4.755

7.  Adenosine A1-receptor blockade impairs the ability of rat pups to autoresuscitate from primary apnea during repeated exposure to hypoxia.

Authors:  James E Fewell; Rongzhi Lun
Journal:  Physiol Rep       Date:  2015-08

Review 8.  Ecologically relevant neurobehavioral assessment of the development of threat learning.

Authors:  Julie Boulanger Bertolus; Anne-Marie Mouly; Regina M Sullivan
Journal:  Learn Mem       Date:  2016-09-15       Impact factor: 2.460

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.